Cargando…
Treatment of malignant hypercalcaemia with aminohexane bisphosphonate (neridronate).
Twenty patients with hypercalcaemia due to malignancy, which persisted following rehydration, were treated with the bisphosphonate, aminohexane bisphosphonate (AHBP), which is structurally similar to pamidronate. The treatment given was a single infusion of 125 mg of AHBP in 500 ml of normal saline...
Autores principales: | O'Rourke, N. P., McCloskey, E. V., Rosini, S., Coleman, R. E., Kanis, J. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968914/ https://www.ncbi.nlm.nih.gov/pubmed/8180023 |
Ejemplares similares
-
Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate.
por: O'Rourke, N. P., et al.
Publicado: (1993) -
Treatment of malignant hypercalcaemia with clodronate.
por: Percival, R. C., et al.
Publicado: (1985) -
A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
por: Purohit, O. P., et al.
Publicado: (1995) -
3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer.
por: Coleman, R. E., et al.
Publicado: (1987) -
Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?
por: Sydlik, Carmen, et al.
Publicado: (2020)